Assignee profile:

Services

City:

Bethesda, Maryland

Country:

United States

Published Applications:

11

Last publication date:

2018-08-23

Patent Grants:

9

Last grant date:

2021-05-25

Top Inventors for applications by Services

These are the the leading inventors for applications assigned to Services:

Recent patent applications by Services

Services based in Bethesda, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2018-08-23 ✅ Patent 11,013,803 granted on 2021-05-25
US20180236076A1
Human necessities

Near infrared photoimmunotherapy (NIR-PIT) of suppressor cells to treat cancer

#2 | 2018-04-19
US20180104289A1
Human necessities

VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER

#3 | 2013-10-03 ✅ Patent 8,999,927 granted on 2015-04-07
US20130261053A1
Chemistry; metallurgy

Glial cell line-derived neurotrophic factor (GDNF) compositions and use thereof

#4 | 2013-08-29
US20130224199A1
Chemistry; metallurgy

VIRAL CHEMOKINE-ANTIGEN FUSION PROTEINS

#5 | 2013-08-22 ✅ Patent 9,096,653 granted on 2015-08-04
US20130216570A1
Chemistry; metallurgy

Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia

#6 | 2013-05-30 ✅ Patent 9,103,788 granted on 2015-08-11
US20130137119A1
Physics

Detection of bacterial contamination in a sample

#7 | 2012-10-04 ✅ Patent 9,181,253 granted on 2015-11-10
US20120252823A1
Chemistry; metallurgy

Adenosine receptor agonists, partial agonists, and antagonists

#8 | 2012-09-20 ✅ Patent 8,440,415 granted on 2013-05-14
US20120237520A1
Physics

BORIS isoforms and methods of detecting and treating disease

#9 | 2011-08-11 ✅ Patent 10,351,587 granted on 2019-07-16
US20110195942A1
Chemistry; metallurgy

Method of making and using 7α, 11β-dimethyl-17β-hydroxyestr-4-en-3-one 17-undecanoate

#10 | 2011-03-03 ✅ Patent 8,075,921 granted on 2011-12-13
US20110052547A1
Human necessities

Rapamycin-resistant T cells and therapeutic uses thereof

#11 | 2010-04-29 ✅ Patent 8,916,159 granted on 2014-12-23
US20100104510A1
Human necessities

Selenocysteine mediated hybrid antibody molecules

AssigneeID:

35857 ⎘